Abbvie Inc
SIX:ABBV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abbvie Inc
SIX:ABBV
|
US |
|
Vericel Corp
NASDAQ:VCEL
|
US |
Wall St Price Targets
ABBV Price Targets Summary
Abbvie Inc
According to Wall Street analysts, the average 1-year price target for ABBV is 191.62 CHF with a low forecast of 141.13 CHF and a high forecast of 256.14 CHF.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABBV's stock price target?
Price Target
191.62
CHF
According to Wall Street analysts, the average 1-year price target for ABBV is 191.62 CHF with a low forecast of 141.13 CHF and a high forecast of 256.14 CHF.
What is the Revenue forecast for Abbvie Inc?
Projected CAGR
9%
Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 9%.
What is the Gross Profit forecast for Abbvie Inc?
Projected CAGR
15%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 3 years is 15%.
What is the Operating Income forecast for Abbvie Inc?
Projected CAGR
25%
Over the last 14 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 3 years is 25%.
What is the Pre-Tax Income forecast for Abbvie Inc?
Projected CAGR
81%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 4%. The projected CAGR for the next 3 years is 81%.
What is the Net Income forecast for Abbvie Inc?
Projected CAGR
98%
Over the last 14 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 3 years is 98%.
